Immunogenic formulation containing BCG expressing a respiratory syncitial virus protein against respiratory viruses.

Abstract

The invention relates to an immunogenic formulation that confers protection against respiratory viruses which comprises an attenuated recombinant strain of Bacillus Calmette and Guerin (BCG), in a concentration of between 104 109 bacteria, which expresses at least one immunogenic protein or fragment of the respiratory syncytial virus (RSV). And to the use of this immunogenic formulation to prepare a vaccine to prevent, treat, or attenuate infections of respiratory viruses, especially hRSV and / or hMPV.